Amanda Ferrier Joins LumaBridge as Chief Operating Officer

SAN ANTONIO–(BUSINESS WIRE)–LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to novel cancer therapies, today announced the appointment of Amanda Ferrier as Chief Operating Officer. Ms. Ferrier brings over 20 years of clinical operations experience in oncology to LumaBridge. Her clinical operations expertise comes from both CROs and sponsor companies including Ilex Oncology; ArQule, Inc.; ICON; Ockham Oncolog

Recent Articles